Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Head and Neck Cancers
•
Radiation Oncology
Is there a role for bromhexine for thick secretions during/after head and neck RT?
How would its use be different from guaifenesin?
Related Questions
What dose would you use for a plaque brachytherapy for a melanoma involving the iris?
How would you approach cT3N0M0 squamous cell carcinoma of the supraglottic larynx in a patient with a history of breast cancer and prior radiation to the supraclavicular fossa?
Would you offer whole lung radiation therapy in a head neck patient who relapsed with multiple lung only mets?
What dose/fractionation would you use for a multiply recurrent and now unresectable ameloblastoma involving the masticator space, pterygopalatine fossa, and right maxillary sinus?
For a small (<5 mm) hard/soft palate junctional primary with DOI <2 mm status post limited excision with negative but close deep margin, how would you approach neck management in the adjuvant RT setting?
What dose and fractionation would you use for Kaposi’s sarcoma of the tonsil post op?
How would you best manage C-spine osteoradionecrosis?
What is the role of radiation therapy for an elderly patient with medullary thyroid cancer who is not a surgical candidate?
How do you manage the thickened secretions secondary to xerostomia during head and neck radiation?
How do you consider the role of probiotics for mucositis mitigation in patients receiving head and neck radiotherapy?